According to our (Global Info Research) latest study, the global Medical Anti-Thrombotic Coating market size was valued at US$ 2202 million in 2025 and is forecast to a readjusted size of US$ 4290 million by 2032 with a CAGR of 10.0% during review period.
In 2025, global Medical Anti-Thrombotic Coating production reached approximately 23.26 k tons, with an average global market price of around US$92,000 per ton.
The gross profit margin of major companies in the industry is between 45%–65%.
In 2025, the global production capacity of medical anti-thrombotic coating was approximately 31.01 k tons.
Medical Anti-Thrombotic Coatings are specialized surface treatments applied to blood-contacting medical devices to reduce platelet adhesion, coagulation, and thrombus formation. These coatings typically utilize heparin-based, hydrophilic polymer, or bioactive formulations to improve hemocompatibility and device safety. They play a critical role in cardiovascular and interventional procedures by lowering the risk of clot-related complications and improving clinical outcomes.
The industrial chain of Medical Anti-Thrombotic Coatings includes upstream bioactive agents, polymers, solvents, and surface modification materials. The midstream focuses on coating formulation, surface treatment processes, curing, and quality validation. Downstream applications cover catheters, guidewires, stents, vascular grafts, extracorporeal circulation devices, and implantable medical products, supported by regulatory compliance, validation testing, and technical services.
The medical anti-thrombotic coating market is driven by the rapid growth of cardiovascular diseases, aging populations, and increasing use of minimally invasive medical devices. As interventional procedures expand, demand for improved blood compatibility and device safety continues to rise. Anti-thrombotic coatings help reduce procedural risks and improve long-term performance of implanted and disposable devices. Advances in polymer science and bioactive materials enable more durable and multifunctional coating solutions. Regulatory emphasis on patient safety further accelerates adoption. Overall, the market is expected to grow steadily as medical device innovation and clinical demand for safer blood-contacting devices continue to increase.
This report is a detailed and comprehensive analysis for global Medical Anti-Thrombotic Coating market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Anti-Thrombotic Coating market size and forecasts, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
Global Medical Anti-Thrombotic Coating market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
Global Medical Anti-Thrombotic Coating market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
Global Medical Anti-Thrombotic Coating market shares of main players, shipments in revenue ($ Million), sales quantity (Kilotons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Anti-Thrombotic Coating
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Anti-Thrombotic Coating market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DSM Biomedical, Surmodics, Specialty Coating Systems (SCS), Biocoat, Coatings2Go, Thermal Spray Technologies, Hydromer, Harland Medical Systems, AST Products, Precision Coating, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Anti-Thrombotic Coating market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Thin Coating
Thick Coating
Market segment by Coating Method
Dip-Coated Anti-Thrombotic Layer
Spray-Coated Anti-Thrombotic Layer
Plasma-Deposited Coating
Market segment by Durability Profile
Short-Term Blood-Contact Coating
Long-Term Implantable Coating
Controlled-Degradation Coating
Market segment by Application
Catheter
Stent Delivery System
Guide Wire
Others
Major players covered
DSM Biomedical
Surmodics
Specialty Coating Systems (SCS)
Biocoat
Coatings2Go
Thermal Spray Technologies
Hydromer
Harland Medical Systems
AST Products
Precision Coating
Surface Solutions Group
ISurTec
Whitford
AdvanSource Biomaterials
Jiangsu Biosurf Biotech
jMedtech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Anti-Thrombotic Coating product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Anti-Thrombotic Coating, with price, sales quantity, revenue, and global market share of Medical Anti-Thrombotic Coating from 2021 to 2026.
Chapter 3, the Medical Anti-Thrombotic Coating competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Anti-Thrombotic Coating breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Anti-Thrombotic Coating market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Anti-Thrombotic Coating.
Chapter 14 and 15, to describe Medical Anti-Thrombotic Coating sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Medical Anti-Thrombotic Coating. Industry analysis & Market Report on Medical Anti-Thrombotic Coating is a syndicated market report, published as Global Medical Anti-Thrombotic Coating Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medical Anti-Thrombotic Coating market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.